O'Brien Patrick
COO at ARWR
- Sold, on record
- $20.7M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Jan 5, 2026
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ARWRARROWHEAD PHARMACEUTICALS, INC.COO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ARWRNoticeJan 4, 2024 2024
Filed to sell 1,700 shares ($55k)
O'Brien Patrick, Officer
10b5-1 plan0.1x usual sizeFiling
- 2 Form 144 notice ARWRNoticeJan 4, 2024 same day
Filed to sell 1,600 shares ($52k)
O'Brien Patrick, Officer
10b5-1 plan0.1x usual sizeFiling
- 3 Form 4 sale ARWRRoutineJan 5, 2024 +1 day
Sold 33,190 shares at $34.36 ($1.1M)
O'Brien Patrick, COO and General Counsel
10b5-1 planSold 6.7% of holdings ($17.1M position)464,385 shares left1.9x usual sizeFollows a Form 144Filing
- 4 Form 144 notice ARWRNoticeJan 5, 2024 same day
Filed to sell 22,841 shares ($806k)
O'Brien Patrick, Officer
10b5-1 plan1.3x usual sizeFiling
- 5 Form 144 notice ARWRNoticeJan 6, 2025 +367 days
Filed to sell 29,184 shares ($578k)
O'Brien Patrick, Officer
10b5-1 planFiling
- 6 Form 4 sale ARWRRoutineJan 7, 2025 +1 day
Sold 37,184 shares at $19.80 ($736k)
O'Brien Patrick, COO and General Counsel
10b5-1 planSold 6.6% of holdings ($11.2M position)527,201 shares leftFollows a Form 144Filing
- 7 Form 144 notice ARWRNoticeJan 7, 2025 same day
Filed to sell 8,000 shares ($158k)
O'Brien Patrick, Officer
10b5-1 planFiling
- 8 Form 4 sale ARWRRoutineJan 5, 2026 +363 days
Sold 49,493 shares at $63.11 ($3.1M)
O'Brien Patrick, COO
10b5-1 planSold 9.4% of holdings ($33.1M position)474,908 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Jan 5, 2026 | ARWR | COO | Form 4 sale | 49,493 | $3.1M | 9.4% | Routine | SEC |
| Jan 7, 2025 | Jan 7, 2025 | ARWR | Officer | Form 144 notice | 8,000 | $158k | Notice | SEC | |
| Jan 7, 2025 | Jan 7, 2025 | ARWR | COO and General Counsel | Form 4 sale | 37,184 | $736k | 6.6% | Routine | SEC |
| Jan 6, 2025 | Jan 6, 2025 | ARWR | Officer | Form 144 notice | 29,184 | $578k | Notice | SEC | |
| Jan 5, 2024 | Jan 5, 2024 | ARWR | Officer | Form 144 notice | 22,841 | $806k | Notice | SEC | |
| Jan 5, 2024 | Jan 5, 2024 | ARWR | COO and General Counsel | Form 4 sale | 33,190 | $1.1M | 6.7% | Routine | SEC |
| Jan 4, 2024 | Jan 4, 2024 | ARWR | Officer | Form 144 notice | 1,600 | $52k | Notice | SEC | |
| Jan 4, 2024 | Jan 4, 2024 | ARWR | Officer | Form 144 notice | 1,700 | $55k | Notice | SEC | |
| Jan 4, 2024 | Jan 4, 2024 | ARWR | Officer | Form 144 notice | 7,049 | $227k | Notice | SEC | |
| Jan 5, 2023 | Jan 6, 2023 | ARWR | COO and General Counsel | Form 4 sale | 15,000 | $561k | 3.5% | Plan not stated | SEC |
| Jan 3, 2023 | Jan 5, 2023 | ARWR | COO and General Counsel | Form 4 sale | 17,500 | $671k | 4.6% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 7, 2022 | ARWR | General Counsel | Form 4 sale | 32,500 | $2M | 8.5% | Plan not stated | SEC |
| Feb 8, 2021 | Feb 10, 2021 | ARWR | General Counsel | Form 4 sale | 90,000 | $8M | 23.5% | Unusual | SEC |
| Jan 6, 2021 | Jan 7, 2021 | ARWR | General Counsel | Form 4 sale | 25,000 | $1.8M | 7.9% | Plan not stated | SEC |
| Jan 6, 2020 | Jan 8, 2020 | ARWR | General Counsel | Form 4 sale | 14,625 | $879k | 5.4% | Plan not stated | SEC |
| May 28, 2019 | May 29, 2019 | ARWR | General Counsel | Form 4 sale | 30,000 | $746k | 12.9% | Plan not stated | SEC |
| Jan 18, 2019 | Jan 18, 2019 | ARWR | General Counsel | Form 4 sale | 72,000 | $1M | 23.6% | Plan not stated | SEC |